SCHEMBL6566938

SCHEMBL6566938

COc1ccc(NC(=O)Nc2ccc(OC(c3ccccc3)c3ccc(C(F)(F)F)cc3)c(C(=O)O)c2)cc1OC

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 6/20 0.47
KMT2A Q03164 6/20 0.47
LMNA P02545 3/20 0.47
HTR2A P28223 1/20 0.46
HTR2C P28335 1/20 0.46
MAPT P10636 4/20 0.45
ALDH1A1 P00352 3/20 0.45
MAPK1 P28482 3/20 0.45
KDM4E B2RXH2 2/20 0.45
HSD17B10 Q99714 2/20 0.45
TP53 P04637 1/20 0.45
GAA P10253 1/20 0.45
ALOX15 P16050 1/20 0.45
CYP1A2 P05177 1/20 0.45
CYP2C9 P11712 1/20 0.45
CYP2C19 P33261 1/20 0.45
RAB9A P51151 2/20 0.44
MCHR1 Q99705 1/20 0.44
PPARA Q07869 2/20 0.44
PPARG P37231 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6564463 0.93 MEN1 (0.47) MEN1KMT2ALMNAHTR2AHTR2C
SCHEMBL6566552 0.93 HTR2A (0.46) MEN1KMT2ALMNAHTR2AHTR2C
SCHEMBL6567894 0.93 MTOR (0.48) MEN1KMT2ALMNAHTR2AHTR2C
SCHEMBL6567699 0.92 MAPT (0.48) MEN1KMT2ALMNAHTR2AHTR2C
SCHEMBL6567864 0.91 KMT2A (0.45) MEN1KMT2ALMNAHTR2AHTR2C
SCHEMBL6564759 0.91 MTTP (0.48) MEN1KMT2ALMNAALDH1A1MCHR1
SCHEMBL6566725 0.90 MAPT (0.43) MEN1KMT2ALMNAHTR2AHTR2C
SCHEMBL6564637 0.90 IMPDH2 (0.44) MEN1KMT2ALMNAHTR2AHTR2C
SCHEMBL6711898 0.89 KMT2A (0.49) MEN1KMT2ALMNAHTR2AHTR2C
SCHEMBL6566926 0.89 MEN1 (0.51) MEN1KMT2ALMNAHTR2AHTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040259912-A1 Benzine derivatives, process for preparing the same and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-12-23 US claimed
US-20040259912-A1 Benzine derivatives, process for preparing the same and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-12-23 US disclosed
EP-1437344-A1 BENZENE DERIVATIVES,PROCESS FOR PREPARING THE SAME AND USE THEREOF Takeda Chemical Industries, Ltd. (JP) 2004-07-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040259912-A1 Benzine derivatives, process for preparing the same and use thereof HRH4, HRH2, HRH1 MEN1 4143/4885KMT2A 3137/4885LMNA 4043/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.